PARIANO, MARILENA
 Distribuzione geografica
Continente #
NA - Nord America 995
EU - Europa 740
AS - Asia 358
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.098
Nazione #
US - Stati Uniti d'America 990
IT - Italia 280
IE - Irlanda 238
HK - Hong Kong 138
SG - Singapore 81
CN - Cina 61
VN - Vietnam 46
DE - Germania 33
RO - Romania 29
RU - Federazione Russa 24
SE - Svezia 24
FR - Francia 20
GB - Regno Unito 19
BE - Belgio 14
AT - Austria 12
KR - Corea 12
UA - Ucraina 11
FI - Finlandia 10
CH - Svizzera 7
CZ - Repubblica Ceca 7
NL - Olanda 6
TR - Turchia 6
CA - Canada 5
JP - Giappone 5
GR - Grecia 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
IN - India 3
BG - Bulgaria 1
BY - Bielorussia 1
EU - Europa 1
ID - Indonesia 1
LB - Libano 1
NZ - Nuova Zelanda 1
Totale 2.098
Città #
Chandler 274
Dublin 231
Hong Kong 137
Perugia 100
San Mateo 71
Ann Arbor 67
Singapore 53
Altamura 52
Dong Ket 46
Medford 42
Princeton 42
Lawrence 40
Wilmington 31
Andover 27
Bucharest 25
Des Moines 21
Boardman 20
Beijing 18
Dearborn 16
Brussels 14
Los Angeles 11
Rome 11
Vienna 11
Redmond 10
Norwalk 9
Seoul 9
Woodbridge 9
Falls Church 8
San Paolo di Civitate 8
Ashburn 6
Brno 6
Kocaeli 6
Redwood City 6
Santarcangelo di Romagna 6
Shenzhen 6
Chicago 5
Saint Petersburg 5
Verona 5
Cambridge 4
Lappeenranta 4
Macerata 4
Milan 4
Spin 4
Timisoara 4
Turin 4
Abidjan 3
Camerino 3
Deruta 3
Fremont 3
Helsinki 3
Houston 3
Munich 3
Nanjing 3
Naples 3
Osaka 3
Pioltello 3
Shanghai 3
Amsterdam 2
Chennai 2
Collazzone 2
Den Haag 2
Dong-gu 2
Edinburgh 2
Frankfurt am Main 2
Groningen 2
Hangzhou 2
Jamaica Plain 2
Monreale 2
Morrovalle 2
Nanning 2
Nürnberg 2
Ottawa 2
Palermo 2
Paris 2
Prata Di Pordenone 2
San Daniele del Friuli 2
Sindelfingen 2
Terracina 2
Tokyo 2
Toronto 2
Zhengzhou 2
Aprilia 1
Arezzo 1
Birmingham 1
Bologna 1
Boydton 1
Böblingen 1
Castel Maggiore 1
Chengdu 1
Civitanova Marche 1
Clearwater 1
Delhi 1
Fairfield 1
Florence 1
Guangzhou 1
Gunzenhausen 1
Hamilton 1
Hefei 1
Hull 1
Kunming 1
Totale 1.595
Nome #
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 106
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis 82
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra 79
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 76
Cellular proteostasis: a new twist in the action of thymosin α1 72
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 64
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 64
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 61
Microbes in the Era of Circadian Medicine 57
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. 53
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 53
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease 52
The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways 49
Circadian Regulation of Xenobiotic Metabolism during Anticancer Treatment 49
Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection 48
Tryptophan Co-Metabolism at the Host-Pathogen Interface 47
To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease 47
Thymosin α1 protects from CTLA-4 intestinal immunopathology 47
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 47
The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface 46
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting 46
Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity 45
Defective Glyoxalase 1 Contributes to Pathogenic Inflammation in Cystic Fibrosis 45
Leucine-rich repeat kinase 2 controls the Ca2+/nuclear factor of activated T Cells/IL-2 pathway during Aspergillus non-canonical autophagy in dendritic cells 44
Selectively targeting key inflammatory pathways in cystic fibrosis 44
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis 43
Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome 43
Thymosin alpha 1 in cystic fibrosis: from the lung to the gut 42
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk 41
Tryptophan as a Central Hub for Host/Microbial Symbiosis 41
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis 39
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 39
A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis 37
A shifted composition of the lung microbiota conditions the antifungal response of immunodeficient mice 36
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 36
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 35
A Reappraisal of Thymosin Alpha1 in Cancer Therapy 35
The microbiota/host immune system interaction in the nose to protect from COVID-19 35
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation 35
Thymosin β4 limits inflammation through autophagy 33
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis 30
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity 24
Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis 20
Small molecule ccr4 antagonists protect mice from aspergillus infection and allergy 19
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line 17
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 17
The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections 17
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models 16
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 14
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections 14
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells 13
Biologics, Theranostics, and Personalized Medicine in Drug Delivery Systems 12
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis 11
Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines 9
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia 9
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems 8
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 5
SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome 5
Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches 3
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 2
Unity Is Strength: The Mutual Alliance between CFTR and SLC26A6 as Therapeutic Opportunity in Cystic Fibrosis 2
Totale 2.260
Categoria #
all - tutte 10.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 5 3 11 0 5 18 3 10 23 10 6 3
2020/2021210 0 16 6 0 56 3 21 13 19 20 5 51
2021/2022419 7 64 9 20 25 8 17 92 13 24 76 64
2022/2023917 48 170 13 69 112 88 7 47 321 4 32 6
2023/2024497 28 57 18 17 26 4 120 7 39 16 79 86
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 2.260